Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.1 USD | -1.35% | +6.19% | +0.18% |
05-24 | Sector Update: Health Care Stocks Softer in Friday Afternoon Trading | MT |
05-24 | Guardant Health's Shares Rise as Colorectal Cancer Detection Test Gets FDA Panel Recommendation | MT |
Sales 2024 * | 681M 926M | Sales 2025 * | 811M 1.1B | Capitalization | 3.32B 4.51B |
---|---|---|---|---|---|
Net income 2024 * | -384M -523M | Net income 2025 * | -342M -466M | EV / Sales 2024 * | 5.24 x |
Net Debt 2024 * | 253M 344M | Net Debt 2025 * | 481M 654M | EV / Sales 2025 * | 4.68 x |
P/E ratio 2024 * |
-8.5
x | P/E ratio 2025 * |
-9.14
x | Employees | 1,774 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.47% |
Latest transcript on Guardant Health, Inc.
1 day | -1.35% | ||
1 week | +6.19% | ||
1 month | +45.86% | ||
3 months | +42.86% | ||
6 months | +2.92% | ||
Current year | +0.18% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Wiley
FOU | Founder | 48 | 11-12-31 |
AmirAli Talasaz
FOU | Founder | 44 | 11-12-31 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 45 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Clark
BRD | Director/Board Member | 62 | 16-11-30 |
Myrtle Potter
BRD | Director/Board Member | 65 | 21-10-14 |
Vijaya Gadde
BRD | Director/Board Member | 49 | 20-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.22% | 0 M€ | -.--% | - | |
0.64% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 27.1 | -1.35% | 3,615,994 |
24-05-30 | 27.47 | +5.29% | 2,077,828 |
24-05-29 | 26.09 | -0.27% | 2,064,970 |
24-05-28 | 26.16 | +2.51% | 3,402,602 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.18% | 3.32B | |
-38.56% | 8.39B | |
+9.29% | 2.48B | |
-18.21% | 2.06B | |
-24.57% | 1.59B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M | |
-6.56% | 273M |
- Stock Market
- Equities
- GH Stock